985 results on '"Shapiro, Jerry"'
Search Results
2. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study
3. A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areata
4. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata.
5. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management
6. Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium
7. To evaluate hypertrichosis with low dose oral minoxidil and spironolactone combination therapy for alopecia
8. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
9. A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States
10. Telogen Effluvium
11. Patterned Hair Loss
12. Cicatricial Alopecia and Inflammatory Scalp Disorders
13. How to Diagnose the Patient with Hair Loss
14. Alopecia Areata
15. Hair Loss and Restoration
16. Contributors
17. Topical immunotherapies
18. Curl pattern classification: A potential tool for communication and risk stratification
19. The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
20. Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework
21. Combating “dread shed”: The impact of overlapping topical and oral minoxidil on temporary hair shedding during oral minoxidil initiation
22. Treatment for central centrifugal cicatricial alopecia—Delphi consensus recommendations
23. Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
24. Minoxidil-induced hypertrichosis: Pathophysiology, clinical implications, and therapeutic strategies
25. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
26. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
27. Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
28. Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster.
29. The use of minoxidil in the treatment of alopecia areata: A systematic review
30. GLP‐1 agonists and hair loss: a call for further investigation
31. Response to “Cetrimonium Bromide Patch Test Positivity Is Found With a High Frequency in a Cohort of Patients With Frontal Fibrosing Alopecia”
32. Navigating Diagnostic Uncertainty: Frontal Fibrosing Alopecia Versus Keratosis Pilaris Atrophicans Faciei With Genetic Testing Insights
33. Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
34. Response to “A Bibliometrics of the Treatment of Alopecia Areata in the Past Twenty Years”
35. Comment on “Baricitinib for the Treatment of Alopecia Areata in Adults: Real World Analysis of 36 Patients”
36. Response to Nathalie Y. Ly and colleagues “Medical and procedural treatment of androgenetic alopecia - Where are we?”
37. Predictors of QOL in Patients with Alopecia Areata
38. Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata
39. Long-Term Efficacy of Ritlecitinib up to Month 24 From the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
40. Response to “Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study”
41. A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris
42. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
43. The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata
44. Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis
45. Review of the use of Janus kinase inhibitors in the treatment of scarring alopecia.
46. Identification of Autoantigen Epitopes in Alopecia Areata.
47. Response to Corona-Rodarte et al.’s “Pressure alopecias: a review”
48. Establishing baselines of hair density measurements: Variations across ethnicity, scalp region, and measurement techniques: A systematic review
49. Understanding perceptions of hair loss in hijab-wearing women: a pilot survey study
50. Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.